Finlepsin review

Finlepsin is an anticonvulsant medication and a mood-stabilizing agent that acts by decreasing the amount of excitement in the brain and is used for epilepsy and the treatment of bipolar disorders. Finlepsin is effective in controlling seizures by blocking specific brain impulses. It is also used effectively to treat ADD (Attention Deficit Disorder), ADHD (Attention Deficit Hyperactive Disorder), and schizophrenia (a psychiatric condition).

Alone or combined with other seizure medications, Finlepsin is used to calm manic episodes where the patient exhibits extreme mood swings, mixed episodes of mania and depression, and other abnormal moods.

Finlepsin can be used in the treatment of trigeminal neuralgia, a condition causing severe pain in the facial nerves. Finlepsin shifts nerve impulses from the affected facial nerves to ease the pain associated with this condition.

Finlepsin is also used to treat mental illnesses including depression, post-traumatic stress disorder, withdrawal from medication and alcohol addictions, restless legs syndrome, diabetes insipidus and a children's disease called chorea.

Patients with bone marrow suppression, porphyria (a blood disorder) and atrioventricular block (a severe heart block problem) should avoid Finlepsin since the medication may make their conditions worse. Patients taking antidepressant medications including amitriptyline (Elavil), desipramine (Norpramin), imipramine (Trofranil), or nortriptyline (Pamelor) should avoid Finlepsin to prevent adverse interactions between the medications.

Other medications that interact negatively with this medication include cold and allergy medicines, pain relievers, sleeping pills, muscle relaxants, antidepressants like isocarboxazid (Marplan) and phenelzine (Nardil), and anti-anxiety medicines like tranylcypromine (Parnate). Patients taking selegiline, a medication to treat early-stage Parkinson's disease and senile dementia, should avoid Finlepsin.

Patients should not consume alcoholic beverages while taking this medication to avoid the risk of seizures. Patients need to let their healthcare professional know if they are taking any prescription or over-the-counter medications, including vitamin, mineral or herbal supplements before starting Finlepsin treatment.

Finlepsin is classified in pregnancy category D by the FDA. This means that this medication may harm an unborn baby. Patients who are pregnant, plan to become pregnant or become pregnant during treatment should talk with their healthcare professional regarding the risks involved. Since this medication can be passed on through breast milk and harm nursing infants, patients should refrain from breastfeeding while taking this medication. Finlepsin may decrease the effectiveness of hormone-based birth control pills. Patients should talk with their healthcare professional regarding alternative birth control options before beginning treatment with this medication. Finlepsin may lower the body's natural infection-fighting blood cells. Patients taking this medication need to have their blood and liver functions checked regularly.

Other side effects include drowsiness, dizziness or headaches, vomiting, anxiety, constipation or diarrhea, heartburn, dry mouth, back pain, and impaired motor coordination or unsteadiness of movement. Though rare, Finlepsin has been known to cause cardiac arrhythmias, blurred eyesight or double vision, and some loss of blood cells or platelets. Consult your healthcare professional if you experience any of these symptoms.

Severe side effects including allergic rashes, breathing difficulties, confusion, depression, suicidal thoughts, chest pain, black or tarry stools, jaundice, and losing touch with reality are rare, but are serious and require immediate medical attention.

Finlepsin is also sold under the brand names Tegretol, Epitol, Sirtal, Stazepine, Talesmin, Teril, Timonil, Trimonil, and Epimaz. The medication is available in tablets, chewables, extended-release tablets and capsules, and a liquid (suspension).

Do not stop taking the medication without consulting your healthcare professional. Suddenly stopping Finlepsin may cause an increase in the number of seizures and produce other unpleasant side effects.

Finlepsin has the following structural formula:

Chemical structure of finlepsin

• Molecular formula of finlepsin is C15H12N2O
• Chemical IUPAC Name is 5H-dibenz[b,f]azepine-5-carboxamide
• Molecular weight is 236.269 g/mol
Finlepsin available : 100mg tablets, 100mg/5ml suspension, 200mg tablets

Generic name: Carbamazepine

Brand name(s): Atretol, Biston, Calepsin, Carbamazepen, Carbamezepine, Carbatrol, Carbazepine, Carbelan, Epitol, Equetro, Karbamazepin, Lexin, Neurotol, Novo-Carbamaz, Nu-Carbamazepine, Sirtal, Stazepin, Stazepine, Taro-Carbamazepine, Tegretal, Tegretol, Telesmin, Teril, Timonil

  Your Finlepsin review